ESC & iPSC News Volume 17.26 | Jul 6 2022

    0
    117







    2022-07-06 | ESC 17.26


    ESC & iPSC News by STEMCELL Technologies
    Vol. 17.26 – 6 July, 2022
    TOP STORY

    Using Human Induced Pluripotent Stem Cell Derived Organoids to Identify New Pathologies in Patients with PDX1 Mutations

    Gastric fundic, antral, and duodenal organoids were generated using iPSC lines from a PDX1188delC/188delC patient and an isogenic iPSC line where the PDX1 point mutation was corrected.
    [Gastroenterology]

    AbstractGraphical Abstract
    ON1104SM-Small-Molecules-Wallchart-728x90
    PUBLICATIONSRanked by the impact factor of the journal

    Dynamic Enlargement and Mobilization of Lipid Droplets in Pluripotent Cells Coordinate Morphogenesis during Mouse Peri-Implantation Development

    Investigators reported that the accumulation and mobilization of lipid droplets upon implantation were causal in the morphogenesis of the pluripotent epiblast and generation of the pro-amniotic cavity in mouse embryos.
    [Nature Communications]

    Full Article

    SETDB1 Acts as a Topological Accessory to Cohesin via an H3K9me3-Independent, Genomic Shunt for Regulating Cell Fates

    A genomic survey of SETDB1 binding in mESCs across multiple libraries was conducted, leading to the unexpected discovery of regions bereft of common repressive histone marks.
    [Nucleic Acids Research]

    Full Article

    Vascular Defects Associated with Hereditary Hemorrhagic Telangiectasia Revealed in Patient-Derived Isogenic iPSCs in 3D Vessels on Chip

    The authors generated hiPSCs from a patient with rare mosaic HHT1 with tissues containing both mutant and normal cells, enabling the derivation of isogenic diseased and healthy hiPSCs, respectively.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Transient DUX4 Expression in Human Embryonic Stem Cells Induces Blastomere-Like Expression Program That Is Marked by SLC34A2

    Researchers reported that a short-pulsed expression of DUX4 in primed hESCs activated an embryonic genome activation-like gene expression program in up to 17% of the cells, retaining cell viability.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Effect of Extracellular Matrix Proteins on the Differentiation of Human Pluripotent Stem Cells into Mesenchymal Stem Cells

    Scientists differentiated hiPSCs and hESCs into human mesenchymal stem cells (hMSCs) on dishes coated with different extracellular matrix proteins to study the effect of cell culture biomaterials on hPSC differentiation into hMSCs.
    [Journal of Materials Chemistry B]

    AbstractGraphical Abstract

    G2019S LRRK2 Mutation Enhances MPP+-Induced Inflammation of Human Induced Pluripotent Stem Cells-Differentiated Dopaminergic Neurons

    The authors generated iPSCs lines from three patients with familial Parkinson’s disease associated with the G2019S mutation in the LRRK2 gene and one age-matched healthy individual.
    [Frontiers in Neuroscience]

    Full Article

    Enhanced Self-Renewal of Human Pluripotent Stem Cells by Simulated Microgravity

    Researchers used a fast-rotating 2D clinostat to investigate the simulated microgravity effect on proliferation, self-renewal, and cell cycle regulation of hPSCs.
    [NPJ Microgravity]

    Full Article

    HDACs Regulate the Differentiation of Endothelial Cells from Human iPSCs

    Scientists utilized a three-stage protocol to induce differentiation of mesoderm, vascular progenitors, and endothelial cells from hiPSCs and investigated the regulatory effects of histone acetylation on the differentiation processes.
    [Cell Biochemistry and Function]

    Abstract
    ON1053ORG-ALI-ISSCR-2021-Innovation-Showcase-1-728x90-2
    REVIEWS

    Human Induced Pluripotent Stem Cells for Studying Mitochondrial Diseases in the Heart

    The authors summarize mitochondrial functions and recent therapeutic discoveries, advancements, and limitations of using iPSC-cardiomyocytes to study mitochondrial diseases of the heart.
    [Febs Letters]

    Abstract
    INDUSTRY AND POLICY NEWS

    Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform

    Inceptor Bio announced a collaboration with the University of Minnesota. The aim of this collaboration is to build a novel iPSC platform that will accelerate Inceptor Bio’s best-in-class next-generation cell therapies platforms.
    [Inceptor Bio]

    Press Release
    FEATURED EVENT

    3D Cell Culture Symposium

    December 1, 2022
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Human iPSC-Derived Cells

    University Hospital Carl Gustav Carus Dresden – Dresden, Germany

    Postdoctoral Research Scientist – Epigenetics

    Babraham Institute – Babraham, England, United Kingdom

    Postdoctoral Fellowship – iPSC Derived Organoid

    University of Oslo – Oslo, Norway

    Postdoctoral Position – Bone and Stem Cell Research

    Uconn Health – Farmington, Connecticut, United States

    Cell Biologist – Alzheimer’s Disease

    Icahn School of Medicine at Mount Sinai – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter